[Possible primary prevention of NIDDM (type 2 diabetes) by pharmacological interventions].
Kawazu
S
S
Second Department of Internal Medicine, Gunma University School of Medicine.
D000368:Aged; D001645:Biguanides / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D005260:Female; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D001645:Biguanides; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds